FrangouGroup
FrangouGroup

2000-2007

Giakoumaki SG, Roussos P, Rogdaki M, Karli C, Bitsios P, Frangou S. Evidence of disrupted prepulse inhibition in unaffected siblings of bipolar disorder patients. Biol Psychiatry. 2007;62(12):1418-22.

 

Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res. 2007;94(1-3):221-30.

 

Vyas NS, Hadjulis M, Vourdas A, Byrne P, Frangou S. The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up. Eur Child Adolesc Psychiatry. 2007; 16(7):465-70.

 

Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S. Comparative profile analysis of cognitive function in recent-onset and chronic patients with adolescent-onset schizophrenia. Schizophr Res. 2007; 94(1-3):240-4.

 

O'Daly OG, Frangou S, Chitnis X, Shergill SS. Brain structural changes in schizophrenia patients with persistent hallucinations. Psychiatry Res. 2007; 156(1):15-21.

 

Frangou S, Lewis M, Wollard J, Simmons A. Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol. 2007;21(4):435-9.

 

Christodoulou T, Lewis M, Ploubidis GB, Frangou S. The relationship of impulsivity to response inhibition and decision-making in remitted patients with bipolar disorder. Eur Psychiatry. 2006;21(4):270-3.

 

Bitsios P, Giakoumaki SG, Theou K, Frangou S. Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males. Neuropsychologia. 2006;44(12):2494-9.

 

Giakoumaki SG, Bitsios P, Frangou S. The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing. Brain Res. 2006;1078(1):168-70.

 

Frangou S, Dakhil N, Landau S, Kumari V. Fronto-temporal function may distinguish bipolar disorder from schizophrenia. Bipolar Disord. 2006;8(1):47-55.

 

Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006;188:46-50.

 

Frangou S, Haldane M, Roddy D, Kumari V. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Biol Psychiatry. 2005;58(10):838-9.

 

Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry. 2005;58(11):859-64.

 

Frangou S. The Maudsley Bipolar Disorder Project. Epilepsia. 2005;46 Suppl 4:19-25.

 

Rapoport JL, Addington AM, Frangou S. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10(5):434-49.

 

Bitsios P, Giakoumaki SG, Frangou S.The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values.Psychopharmacology (Berl). 2005 Oct;182(1):144-52.

 

Frangou S, Chitniss X, Williams SC.Mapping IQ and gray matter density in healthy young people. Neuroimage. 2004;23(3):800-5.

 

Reeder C, Newton E, Frangou S, Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophr Bull. 2004;30(1):87-100.

 

Hadjulis M, Pipe R, Frangou S. Normal cerebral volume asymmetries in early onset schizophrenia. Biol Psychiatry. 2004;55(2):148-53.

 

Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S. The Maudsley Early-Onset Schizophrenia Study: cognitive function in adolescent-onset schizophrenia. Schizophr Res. 2003; 65(2-3):95-103.

 

Vourdas A, Pipe R, Corrigall R, Frangou S. Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophr Res. 2003;62(1-2):13-22.

 

Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S. The Maudsley early onset schizophrenia study: cognitive function in adolescents with recent onset schizophrenia. Schizophr Res. 2003;61(2-3):137-48.

 

Raymont V, Bettany D, Frangou S. The Maudsley bipolar disorder project. Clinical characteristics of bipolar disorder I in a Catchment area treatment sample. Eur Psychiatry. 2003 Feb;18(1):13-7.

 

Frangou S. Predictors of outcome in a representative population of bipolar disorder. Bipolar Disord. 2002;4 Suppl 1:41-2.

 

Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord. 2002;72(3):209-26.

 

Frangou S, Raymont V, Bettany D. The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder. Bipolar Disord. 2002;4(6):378-85.

 

Matsumoto H, Simmons A, Williams S, Pipe R, Murray R, Frangou S. Structural magnetic imaging of the hippocampus in early onset schizophrenia. Biol Psychiatry. 2001;49(10):824-31.

 

Matsumoto H, Simmons A, Williams S, Hadjulis M, Pipe R, Murray R, Frangou S. Superior temporal gyrus abnormalities in early-onset schizophrenia: similarities and differences with adult-onset schizophrenia. Am J Psychiatry. 2001;158(8):1299-304.

 

Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry. 2001;64(1):86-93.

Latest Publication

Visitors Count

 

To learn more about our research or to participate in our studies email us at

 

prp@mssm.edu

 

or call us on

 

212 659 1668

 

Print Print | Sitemap
© FrangouGroup

This website was created using 1&1 MyWebsite.